Genetically modified filamentous phage as bactericidal agents: a pilot study.
about
Natural solution to antibiotic resistance: bacteriophages 'The Living Drugs'Dispersing biofilms with engineered enzymatic bacteriophageGenetically Engineered Phages: a Review of Advances over the Last DecadeBeyond phage display: non-traditional applications of the filamentous bacteriophage as a vaccine carrier, therapeutic biologic, and bioconjugation scaffold.Chemical strategies for the covalent modification of filamentous phageBacteriophages and phage-derived proteins--application approachesBacteriophage-based synthetic biology for the study of infectious diseases.Plasmid addiction systems: perspectives and applications in biotechnology.Phage treatment of human infections.Aeromonas punctata derived depolymerase improves susceptibility of Klebsiella pneumoniae biofilm to gentamicin.Pharmacogenomic strategies against resistance development in microbial infections.Enhancing the utility of existing antibiotics by targeting bacterial behaviour?Real-time kinetics of restriction-modification gene expression after entry into a new host cellPhage-mediated Delivery of Targeted sRNA Constructs to Knock Down Gene Expression in E. coliEngineered bacteriophage targeting gene networks as adjuvants for antibiotic therapyNovel avenues for Clostridium difficile infection drug discovery.Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.Phage therapy: eco-physiological pharmacology.Phage approved in food, why not as a therapeutic?Genetically modified bacteriophages.Genetically modified bacteriophages in applied microbiology.Lysis-deficient phages as novel therapeutic agents for controlling bacterial infection.A tale of tails: Sialidase is key to success in a model of phage therapy against K1-capsulated Escherichia coli.Bacteriophages: The possible solution to treat pathogenic bacteria.Therapy of experimental pseudomonas infections with a nonreplicating genetically modified phage.Mycobacteriophage putative GTPase-activating protein can potentiate antibiotics.Drug delivery vectors based on filamentous bacteriophages and phage-mimetic nanoparticles.Cangene gold medal award lecture - Genomic analysis and modification of Burkholderia cepacia complex bacteriophages.
P2860
Q24563742-6CC19821-324C-4A63-B1DC-5CA244BBC4B0Q24684087-F5FC2CEC-D7D8-466E-B95B-1DC794465948Q26744156-B935D476-B21C-44AA-9016-2557177C23F9Q26795483-7F4947EA-CA8E-44F9-B1B9-50150091A22EQ26992196-1547A14E-7803-4723-AB3B-8932300A0504Q28082731-0D45CC6D-9C0F-46B9-A7A7-87D0A36FA608Q34017160-8E5FD4BA-9840-46FD-ACD0-037EF975C1B8Q34160193-78F564FB-52FD-4DB1-856C-9D0494DE1D96Q34254407-068E7242-67B4-4181-B60A-6D3F29A55678Q35660517-E7B9F790-F367-4BE1-988C-A2286E6C232BQ35785222-66F93B87-94BB-41CB-9B25-46FC5ABE1847Q35853204-DE62D63F-C677-4E5F-994C-3F9936887646Q36649639-8ED12AF3-D8CE-48CA-811D-1A68FFD1A145Q36790925-CAE56BD1-FC93-4427-BA41-6933F5AF1E7EQ37114251-D5459765-634B-44AF-934B-939911A78862Q38083297-51D7C2F8-B15A-4F5A-B269-61D3D216693AQ38215724-0E8BA204-D65C-4F48-82F8-D674FCC01627Q38230407-4F5C3416-A302-4EE8-9039-C99B60B446A8Q38285489-6D75A60B-D2CC-44C0-B306-A7DA99749A8CQ38746993-CD063109-F58B-4976-93F3-081780B9411BQ38870317-5A30D83C-E49A-4122-A370-1ED07376C898Q39374494-343143D7-B23D-4759-96B4-F9FF66581EF8Q39747962-28F73103-1915-4730-8521-9CC06616A948Q40070554-BAC597C6-4907-438A-A4E1-0C6F3D63122CQ40164333-5BF46F67-8F07-48A2-A727-D9C1CBB5E96BQ40636542-C87B4AAF-20F1-48C2-A612-6ECF59AA4131Q47298251-60A085F8-14D4-439C-8388-F22ED8AFA6DDQ48293875-3CBFBA65-FE91-4105-97D2-C4FAA547328E
P2860
Genetically modified filamentous phage as bactericidal agents: a pilot study.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Genetically modified filamentous phage as bactericidal agents: a pilot study.
@en
Genetically modified filamentous phage as bactericidal agents: a pilot study.
@nl
type
label
Genetically modified filamentous phage as bactericidal agents: a pilot study.
@en
Genetically modified filamentous phage as bactericidal agents: a pilot study.
@nl
prefLabel
Genetically modified filamentous phage as bactericidal agents: a pilot study.
@en
Genetically modified filamentous phage as bactericidal agents: a pilot study.
@nl
P2860
P1476
Genetically modified filamentous phage as bactericidal agents: a pilot study.
@en
P2093
P2860
P304
P356
10.1046/J.1472-765X.2003.01400.X
P577
2003-01-01T00:00:00Z